AI-generated summary
In mice with melasma-like skin and in cultured melanoma cells, the authors tested four picosecond laser modes and report that a combination of large-spot low-fluence and fractional 1064-nm treatment reduced melanin and melanin-synthesizing enzymes and increased autophagy-related proteins. The authors describe this combination as more effective and safer and suggest it acts through the PI3K/AKT/mTOR pathway. The study used mice and cell cultures, so these findings have not been tested in human patients.
- Who or what was studied
- Female Kunming mice with melasma-like conditions and mouse melanoma B16-F10 cells
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The study was conducted in mice and cultured cells rather than in human patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Melanin, Fluence, Laser, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.